Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Get Free Report) insider Mark Bodenrader sold 7,889 shares of the business’s stock in a transaction on Wednesday, December 20th. The stock was sold at an average price of $41.42, for a total value of $326,762.38. Following the completion of the transaction, the insider now directly owns 17,724 shares […]
Cerevel Therapeutics Holdings, Inc (NASDAQ:CERE) Short Interest Update theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright lowered shares of Cerevel Therapeutics (NASDAQ:CERE – Free Report) from a buy rating to a neutral rating in a report released on Thursday, MarketBeat reports. They currently have $45.00 price target on the biotechnology company’s stock, up from their previous price target of $41.00. A number of other research firms have also recently […]
Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Get Free Report) saw unusually-high trading volume on Monday . Approximately 1,343,201 shares traded hands during mid-day trading, an increase of 45% from the previous session’s volume of 927,215 shares.The stock last traded at $41.07 and had previously closed at $41.22. Wall Street Analysts Forecast Growth CERE […]
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Get Free Report) insider Scott Akamine sold 10,000 shares of the company’s stock in a transaction on Thursday, December 7th. The stock was sold at an average price of $41.37, for a total value of $413,700.00. Following the completion of the sale, the insider now owns 513 shares of […]